Jacob Jaremko is a clinician-scientist, currently an Associate Professor in the Faculty of Medicine at the University of Alberta, a practicing Pediatric and Musculoskeletal radiologist and partner at Medical Imaging Consultants, and co-founder of MEDO.ai. His research has focused on the influence of anatomy & childhood development of joints on the development of adult osteoarthritis. Seeking to develop objective imaging biomarkers of disease, he has generated 3D ultrasound tools for assessment of infant hip dysplasia, and semi-quantitative MRI scoring systems for arthritis.
Medical images are becoming easier to acquire than to interpret reliably. Dr. Jaremko is increasingly focused on automating medical image analysis, particularly in ultrasound, using artificial intelligence. Tools from natural image and video processing can be adapted to medical image analysis, with special attention to problems such as small training data sets and extreme class imbalance. A handheld ultrasound probe with AI image interpretation could ultimately be used by clinicians at any point of care -- becoming the 21st-century stethoscope!
MEDO.ai is one of Edmonton's many startup success stories, offering an AI platform that makes obtaining and interpreting ultrasound images faster, more reliable and accessible to all. However, many are unaware of the academic origins of the technology – let alone how Medo transitioned from academic advancement into a commercial success. In this special Edmonton Startup Week edition of the AI Seminar, join Amii Fellow and Canada CIFAR AI Chair Jacob Jaremko, also a clinician-scientist and co-founder of MEDO.ai, as he walks us through the company's origins and the steps the team took to launch what has grown into a key member of the Edmonton startup community.